Jul 31, 2020 – IBM Hyper Protect Accelerator uses R2GConnect platform to crowdsource startups handling highly sentisitive information

IBM Hyper Protect Accelerator works together with R2GConnect to identify early-stage startups that collect, store, and/or transmit sensitive data such as medical and/or financial records. Selected digital health startups will get access to one-on-one, first-hand technical advice from the industry leaders and support from the experienced network of business gurus. Startups will also get up […]

IBM Hyper Protect Accelerator works together with R2GConnect to identify early-stage startups that collect, store, and/or transmit sensitive data such as medical and/or financial records. Selected digital health startups will get access to one-on-one, first-hand technical advice from the industry leaders and support from the experienced network of business gurus. Startups will also get up to 120,000 USD in IBM cloud credits without any equity.

In order to provide a wide range of business expertise and mentorship to the startups, IBM Hyper Protect Accelerator program collaborates with  Village CapitalFemale Founders AllianceMEDICISociety of Physician EntrepreneursQueen City Fintech, and Healthtech Women.

IBM Hyper Protect Accelerator program is designed for early-stage startups from across the globe that are less than five years old and has less than $1M USD in revenue.

 

Here are the three deal makers questions for startups:

  • Are you collecting, storing, and/or transmitting personally identifiable information (PII) such as individual medical records, individual financial records, and/or individual insurance records?
  • Please describe your company’s value proposition
  • At which stage is your product?

Ready to answer these questions? Submit your application here.

 

The application deadline is July 31, 2020.

 

If you would like to explore more business opportunities or send a briefing to have full access to R2GConnect digital health startups community, get in touch with Nazareno Quines Jr. | nazareno.quines@research2guidance.com